{"grounding": "Lysosomes play fundamental roles in material digestion, cellular clearance, recycling, exocytosis, wound repair, Ca2+ signaling, nutrient signaling, and gene expression regulation. The organelle also serves as a hub for important signaling networks involving the mTOR and AKT kinases. Electrophysiological recording and molecular and structural studies in the past decade have uncovered several unique lysosomal ion channels and transporters, including TPCs, TMEM175, TRPMLs, CLN7, and CLC-7. They underlie the organelle's permeability to major ions, including K+, Na+, H+, Ca2+, and Cl\u2212. The channels are regulated by numerous cellular factors, ranging from H+ in the lumen and voltage across the lysosomal membrane to ATP in the cytosol to growth factors outside the cell. Genetic variations in the channel/transporter genes are associated with diseases that include lysosomal storage diseases and neurodegenerative diseases. Recent studies with human genetics and channel activators suggest that lysosomal channels may be attractive targets for the development of therapeutics for the prevention of and intervention in human diseases.", "generated_text": "Lysosomal ion channels, including two-pore channels (TPCs), transient receptor potential mucolipin channels (TRPMLs), and TMEM175, play crucial roles in maintaining cellular homeostasis by regulating ion fluxes within lysosomes. These channels are integral to lysosomal functions such as autophagy, endocytosis, and lysosomal exocytosis, which are vital for cellular waste management and nutrient recycling. Dysregulation of lysosomal ion channels has been implicated in various neurodegenerative diseases, including Parkinson's and Alzheimer's, highlighting their potential as therapeutic targets. Recent advances in structural biology and pharmacology have provided insights into the mechanisms of these channels, paving the way for the development of small-molecule modulators. This review explores the physiological roles of lysosomal ion channels, their involvement in neurodegenerative pathologies, and evaluates their druggability. By understanding the molecular underpinnings of these channels, novel therapeutic strategies can be devised to modulate their activity, offering promising avenues for the treatment of neurodegenerative disorders.", "label": 1}